Hepatocellular carcinoma (HCC) is prevalent in Asia and is the third leading cause of cancer death in Korea.
1 x 1 Korea National Statistical Office. Annual Report on the Cause of Death Statistics of 2005, Seoul, 2006. Google Scholar See all References With recent advances in diagnosis and treatment, an increasing number of patients are eligible for hepatic resection at an early stage and hepatic resection has been established as a safe and an effective treatment modality. However, the long-term prognosis of HCC remains unsatisfactory because of a high incidence of tumor recurrence after hepatic resection. Even though intrahepatic recurrence is more common than extrahepatic recurrence, transarterial chemoembolization (TACE), percutaneous ethanol injection and radiofrequency ablation, and hepatic reresection or orthotopic liver transplantation have improved the prognosis of HCC significantly.
2 x 2 Lee, PH, Lin, WJ, Tsang, YM et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg. 1995; 222: 670–676 Crossref | PubMed | Scopus (89) | Google Scholar See all References
, 3 x 3 Shimada, M, Takenaka, K, Gion, T et al. Prognosis of recurrent hapatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 1996; 111: 720–726 Abstract | Full Text | Full Text PDF | PubMed | Scopus (235) | Google Scholar See all References
, 4 x 4 Farges, O, Regimbeau, JM, and Belghiti, J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology. 1998; 45: 1275–1280 PubMed | Google Scholar See all References
, 5 x 5 Poon, RTP, Fan, ST, Lo, CM et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors. Ann Surg. 1999; 229: 216–222 Crossref | PubMed | Scopus (457) | Google Scholar See all References
, 6 x 6 Bates, MJ, Farkas, E, Taylor, D et al. Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation. Ann Thorac Surg. 2008; 85: 412–415 Abstract | Full Text | Full Text PDF | PubMed | Scopus (24) | Google Scholar See all References Unlike in case with intrahepatic metastasis, there is no definitive treatment for HCC with extrahepatic metastasis although some chemotherapeutic agents have been known to be effective in selective patients.
7 x 7 Mnedez-Sanchez, N, Vasquez-Fernandez, F, Zamora-Valdes, D et al. Sorafenib, systemic therapy for hepatocellular carcinoma. Ann Hepatol. 2008; 7: 46–51 PubMed | Google Scholar See all References In recent studies, pulmonary metastasectomy has been found to improve long-term survival in highly selective cases.
8 x 8 Lam, CM, Lo, CM, Yuen, WK et al. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg. 1998; 85: 1198–2000 Crossref | PubMed | Scopus (102) | Google Scholar See all References
, 9 x 9 Tominaru, Y, Sasaki, Y, Yamada, T et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg. 2006; 192: 46–51 Abstract | Full Text | Full Text PDF | PubMed | Scopus (64) | Google Scholar See all References
, 10 x 10 Nakagawa, T, Kamiyama, T, Nakanishi, K et al. Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg. 2006; 131: 1248–1254 Abstract | Full Text | Full Text PDF | PubMed | Scopus (34) | Google Scholar See all References However, because only a few cases of pulmonary metastasectomy have been described, its role in the treatment of pulmonary metastasis from HCC is still unclear. Further, the indications and prognostic factors have not yet been standardized. This study aimed to present our experience with pulmonary metastasectomy from HCC and evaluate the prognostic factors.